Gene Query: COX7C

Dataset Description Geneva Score
Alteration of the microRNA network during the progression of Alzheimer’s disease 202.74
Altering cancer transcriptomes using epigenomic inhibitors 185.79
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 185.79
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 102.18
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 95.83
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 95.83
mRNA expression in human DAOY cells 69.39
The regulartory role of ZCCHC24 in splicing machinery 51.75
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 43.5
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 43.37
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 42.98
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 41.04
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 39.98
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 37.88
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 36.89
Role of microRNAs in the interaction between Salmonella and the host cell 36.79
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 35.67
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 35.14
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 34.17
NRDE2 negatively regulates nuclear exosome functions 33.22
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 32.65
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 31.68
Next generation sequencing of small RNAs isolated from exosomes in human semen 30.18
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 29.91
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 29.91
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 28.81
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 28.61
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 28.12
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 27.79
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 26.26
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 25.92
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 25.49
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 25.16
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 24.47
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 23.88
Mitochondrial dsRNA triggers antiviral signalling in humans 23.58
N6-methyladenine DNA Modification in Glioblastoma 23.39
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 23.39
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 22.66
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 22.59
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 21.8
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 21.72
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 21.67
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 21.54
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 21.43
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 21.03
RNA-sequencing of healthy human skeletal myocytes 20.75
Sensing self and nonself circular RNAs 20.44
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 20.19
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 20.08
Human cells contain natural double-stranded RNAs with potential regulatory capacity 19.63
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 19.55
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 19.55
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 18.99
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 18.95
LncRNA expression profiling of ischemic stroke patients 18.89
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 18.77
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 18.77
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 18.25
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 18.17
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 17.93
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 17.75
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 17.39
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 17.39
Ribosomal footprinting of MDA-Parental and MDA-LM2 17.37
Global analysis of enhancer targets: Mosaic-seq 17.19
3’ Uridylation Expands miRNA Target Repertoire 17.19
Transcriptomic analysis of the HOTAIR-regulated genes 17.13
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 16.96
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 16.86
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 16.73
Gene expression changes caused by KRAS in MCF-10A 16.64
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 16.17
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 16.08
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 16.02
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 15.8
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 15.78
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 15.51
Profiling of escape kinetics of viruses subjected to RNAi 15.49
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 15.35
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 15.2
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 15.2
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 15.16
Exploring the RNA landscape of endothelial exosomes 15.15
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 15.07
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 15.03
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 14.92
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 14.92
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 14.61
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 14.28
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 14.15
RNA-Seq with and without RNase treatment in PCa cell lines 14.07
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 14.06
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.95
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 13.89
BCL11B 13.67
RNA sequencing of primary human platelets and in vitro cell lines 13.49
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.43
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 13.32
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 13.31
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 13.21
RNA-seq melanoma 13.09
Transcriptomic analyssis following EHMT1/2 inhibition 13.06
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 13.05
Differetially expressed genes after hTR overexpression in U2OS cells 13.05
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 13.01
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 13.01
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 13.01
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 13.0
Determining mRNA half-lives on a transcriptome-wide scale 12.97
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 12.9
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 12.88
miR941 overexpression experiment 12.88
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 12.73
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 12.57
U1 snRNP telescripting regulates size-function stratified human genome 12.55
CROP-Seq in Primary Human T Cells 12.38
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 12.36
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 12.36
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 12.36
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 12.36
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 12.24
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 12.24
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 12.2
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 12.2
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 12.18
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 12.14
The human blood-nerve barrier transcriptome 12.01
High-throughput sequencing of PROMPT-enriched samples. 11.97
Determination of tRNA aminoacylation levels by high throughput sequencing 11.97
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 11.96
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 11.94
Novel Targeting of Transcription and Metabolism in Glioblastoma 11.88
Reassessment of Exosome Composition 11.87
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 11.86
RNA m5C Methylation in breast cancer using MeRIP-Seq 11.79
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 11.73
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 11.73
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 11.7
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 11.67
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 11.6
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 11.58
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 11.58
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 11.52
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.47
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 11.46
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 11.42
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 11.42
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 11.29
RNA-sequencing of formalin fixed human primary melanoma tissue 11.28
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 11.24
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 11.23
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 11.23
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 11.19
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 11.18
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 11.18
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 11.16
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 11.16
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 11.09
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 11.03
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.03
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.94
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.94
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 10.83
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 10.58
Measure transcript integrity using RNA-seq data 10.56
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 10.56
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 10.55
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 10.55
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.42
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.42
RNA transcriptome analysis during HSV-1 infection 10.25
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 10.23
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 10.13
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 10.1
Transcriptome sequencing of K-562 cells 10.09
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.07
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.07
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 9.88
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 9.85
Systematic discovery of endogenous human ribonucleoprotein complexes 9.84
Global Mapping of Human RNA-RNA Interactions 9.73
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.73
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 9.73
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 9.72
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 9.7
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 9.69
Human cell line and subcutaneous tumor 9.67
Nucleoporin-mediated regulation of cell identity genes 9.65
MEIS1 regulates hematopoiesis in hPSCs 9.65
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.64
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 9.64
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.6
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 9.59
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.59
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 9.5
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.5
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 9.43
Loss of CREBBP results in gene expression repression in lymphoma cells 9.43
Survival of pancreatic cancer cells lacking KRAS function 9.39
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 9.38
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.37
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 9.32
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.28
Patient-derived xenograft platform for metastatic melanoma 9.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 9.25
Identification of Atrial Fibrillation associated genes and functional non-coding variants 9.18
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.13
Total RNA-seq in ALL-SIL upon TLX1 knockdown 9.13
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 9.11
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 9.11
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 9.1
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.04
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.04
Expression profiling of etoposide-induced senescent cells 8.97
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.96
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 8.83
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 8.8
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.73
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.71
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 8.71
Hepatocyte maturation 8.67
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 8.64
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 8.63
Efficient and quantitative high-throughput tRNA sequencing 8.52
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.51
Knockdown of ADNP in HCT116 colon cancer cells 8.46
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.42
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.42
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 8.38
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.35
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 8.29
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 8.29
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 8.23
Single-cell analysis of human kidney organoids 8.16
The age and genomic integrity of neurons after cortical stroke in humans 8.1
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.1
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.09
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 8.09
Gene expression analysis upon mtDNA depletion 8.08
Gene expression analysis upon mtDNA depletion [RNA-seq] 8.08
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 8.04
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 8.04
In vitro modeling of human germ cell development using pluripotent stem cells 7.9
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 7.84
Comparison of microRNA Profiling Platforms (HTS) 7.78
Comparison of microRNA Profiling Platforms 7.78
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 7.74
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 7.74
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.72
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 7.7
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.69
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.66
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.66
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.63
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 7.61
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 7.6
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.55
RNA editing in nascent RNA affects pre-mRNA splicing 7.53
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 7.51
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.46
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.46
RNA-seq analysis of the human fetal kidney. 7.45
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.41
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.36
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 7.26
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 7.26
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.17
Microprocessor mediates transcription termination in long noncoding microRNA genes 7.16
RNA-seq of RKO cells with cTAZ KO or putback 7.13
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 7.08
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 7.07
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 7.04
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 6.95
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 6.92
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.88
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 6.82
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.81
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.77
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.72
Identification of renal resident macrophages across species 6.56
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 6.51
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 6.51
METTL3 and WTAP 6.49
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 6.47
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.43
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 6.38
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.34
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.32
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 6.3
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.23
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 6.22
Transcription elongation regulates genome 3D structure 6.17
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.14
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.14
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.11
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.03
Trans-differentiation of human adult peripheral blood T cells into neurons 6.03
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.98
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 5.88
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.83
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.83
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 5.78
O-glcnAc reprograms cellular energetics 5.75
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.74
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.74
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.71
Regulatory network controlling tumor-promoting inflammation in human cancers 5.71
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 5.69
KLF6-dependent transcription in renal cancer cells 5.66
Regulation of poly(A) tail and translation during the somatic cell cycle 5.65
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.61
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 5.57
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.55
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.55
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 5.46
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.41
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.33
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 5.33
Exogenous rescue of KLHL9 in SF210 cell line 5.29
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 5.19
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.19
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.12
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.11
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 5.1
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 5.07
RNAseq in Alzheimer's Disease patients 5.01
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.97
RNA-seq of IL-4 stimulated human keratinocytes 4.92
Expression analysis of the TAF1 syndrome 4.88
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 4.81
Differential gene expression profiles in imatinib-resistant cell lines 4.81
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.75
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.73
Effect of PRDM11 depletion in U2932 cells 4.71
The pioneer factor CEBPA modulates vitamin D signaling 4.64
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 4.64
A20 regulates canonical wnt-signaling through an interaction with RIPK4 4.58
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.58
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 4.56
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.36
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.36
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 4.31
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.25
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 4.23
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.14
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.14
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 4.08
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.96
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.91
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.91
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.88
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.86
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 3.81
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 3.81
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.79
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 3.77
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 3.76
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 3.76
The transcriptome of Kawasaki Disease arteritis 3.73
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.69
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.68
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.68
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.67
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.67
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 3.6
LIN28A Over-expression RNAseq 3.6
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.58
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 3.54
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.54
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.51
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.51
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 3.47
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.42
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.42
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.4
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.4
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.39
naive T cell heterogeneity after neonatal thymectomy 3.34
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 3.26
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 3.22
Iron response of HepG2 cells 3.13
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 2.97
Dilated cardiomyopathy vs Myocarditis 2.95
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.87
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.86
Changes in human endometrial gland transcriptome over the window of implantation 2.82
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 2.79
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.71
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.67
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.66
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.63
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.62
A single-cell transcriptome atlas of the human pancreas 2.6
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.59
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.57
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.52
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.48
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.44
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.44
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.43
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.36
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.31
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.31
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.28
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.17
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.16
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.15
Copper Regulation of HIF-1 Transcription Activity 2.15
MARCKS and lnc-MARCKS act as inflammation regulators 2.11
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.08
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.07
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.07
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.07
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.03
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.03
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.01
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.94
HBEC-shp53-PCHD7 1.94
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.93
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.93
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.91
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 1.89
Comparative Analysis of Cas9 Activators Across Multiple Species 1.87
Identification of renal resident macrophages across species [C1] 1.86
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.86
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.85
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.75
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.71
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.67
Interphase condensins regulate ligand-depedent enhancer activation 1.64
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.64
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.62
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.6
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.58
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.58
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.56
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.52
Transcriptome-wide response to synthetic chromatin protein PcTF 1.5
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.33
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.29
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.27
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.27
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 1.24
Human Tfh cell RNA bulk sequencing 1.16
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.13
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.1
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.1
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.07
Aging-associated patterns in the expression of human endogenous retroviruses 1.06
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.05
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.05
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.01
Activity-dependent transcriptional changes in human neurons 0.98
Role of cervicovaginal microbiota in genital inflammation 0.97
Total RNA-Seq data from leukemic patients with complex structural variants 0.92
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.86
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.85
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.84
Induced DNA demethylation, genome instability and transcription 0.82
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.82
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.78
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.74
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.71
Dermal endothelial cells of type 2 diabetic patients 0.67
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.67
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.62
mRNA recovered upon RNF219 IP. [RNA-IP] 0.62
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.61
RNA seq_PDX2_SHP099 0.59
RNA-seq data 0.58
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.55
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.52
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.51
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.45
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.45
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.44
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.44
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.44
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.27
hESC neural differentiation 0.25
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.25
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.24
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.22
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.21
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.18
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 0.14
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 0.14
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.14
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.13
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
siRNA-mediated knockdown 0.06
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.03
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.02
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation